Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...
Nasdaq

Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System

Medtronic "Conduction System Pacing" Expanded Indication Now Includes Left Bundle Branch Area Pacing in Addition to His-Bundle Pacing for Patients with Slow Heart Rates Medtronic is the first and only ...
Medscape

FDA OKs Medtronic Lead for Left Bundle Branch Pacing

Labeling for a Medtronic pacing lead, already indicated for stimulation of the His bundle, has been expanded to include the left bundle branch (LBB), the company announced today. The US Food and Drug ...
FierceBiotech

Medtronic scores FDA approval for pacemaker hardware that taps into heart's natural electrical signals

Medtronic has secured a new approval from the FDA that expands the flexibility of its pacemaker hardware, allowing it to tap into the heart’s natural electrical signals. Known as conduction system ...
Seeking Alpha

Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025: ...
Medical Device Network on MSN

Medtronic’s OmniaSecure defib lead nets another FDA approval

OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.